Uncoupling of neuroinflammation from axonal degeneration in mice lacking the myelin protein tetraspanin-2

GLIA

Volumn 61, Issue 11, 2013, Pages 1832-1847

  de Monasterio Schrader, Patricia ^a   Patzig, Julia ^a   Möbius, Wiebke ^a,b   Barrette, Benoit ^a   Wagner, Tadzio L ^a   Kusch, Kathrin ^a   Edgar, Julia M ^a,c   Brophy, Peter J ^d   Werner, Hauke B ^a  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^b Cluster of Excellence Nanoscale Microscopy and Molecular Physiology of the Brain   (Germany)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Astrocyte; Microglia; Oligodendrocyte; Proteolipid protein; Spastic paraplegia

Indexed keywords

MYELIN; MYELIN PROTEIN; PROTEOLIPID PROTEIN; TETRASPANIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BIOGENESIS; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EMBRYONIC STEM CELL; HOMOLOGOUS RECOMBINATION; MALE; MICROGLIA; MOUSE; MYELIN DEFICIENCY; MYELINATION; NERVE FIBER DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

ASTROCYTE; MICROGLIA; OLIGODENDROCYTE; PROTEOLIPID PROTEIN; SPASTIC PARAPLEGIA;

ANIMALS; AXONS; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; INFLAMMATION; MALE; MICE; MICE, TRANSGENIC; MICROGLIA; MUTATION; MYELIN PROTEINS; MYELIN SHEATH; NERVE FIBERS, MYELINATED; NERVE TISSUE PROTEINS; TETRASPANINS;

EID: 84884715243     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22561     Document Type: Article

References (101)

1. Aguzzi A, Barres BA, Bennett ML. 2013. Microglia: Scapegoat, saboteur, or something else? Science 339:156-161.
2. Bakhti M, Snaidero N, Schneider D, Aggarwal S, Mobius W, Janshoff A, Eckhardt M, Nave KA, Simons M. 2013. Loss of electrostatic cell-surface repulsion mediates myelin membrane adhesion and compaction in the central nervous system. Proc Natl Acad Sci U S A 110:3143-3148.
3. Bassani S, Cingolani LA. 2012. Tetraspanins: Interactions and interplay with integrins. Int J Biochem Cell Biol 44:703-708.
4. Berditchevski F. 2001. Complexes of tetraspanins with integrins: More than meets the eye. J Cell Sci 114(Pt 23):4143-4151.
5. Birling MC, Tait S, Hardy RJ, Brophy PJ. 1999. A novel rat tetraspan protein in cells of the oligodendrocyte lineage. J Neurochem 73:2600-2608.
6. Bizzozero OA, Bixler HA, Davis JD, Espinosa A, Messier AM. 2001. Chemical deacylation reduces the adhesive properties of proteolipid protein and leads to decompaction of the myelin sheath. J Neurochem 76:1129-1141.
7. Bizzozero OA, Howard TA. 2002. Myelin proteolipid protein-induced aggregation of lipid vesicles: Efficacy of the various molecular species. Neurochem Res 27:1269-1277.
8. Bosse F, Hasse B, Pippirs U, Greiner-Petter R, Muller HW. 2003. Proteolipid plasmolipin: Localization in polarized cells, regulated expression and lipid raft association in CNS and PNS myelin. J Neurochem 86:508-518.
9. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, Xing Y, Lubischer JL, Krieg PA, Krupenko SA, Thompson WJ, Barres BA. 2008. A transcriptome database for astrocytes, neurons, and oligodendrocytes: A new resource for understanding brain development and function. J Neurosci 28:264-278.
10. Cailloux F, Gauthier-Barichard F, Mimault C, Isabelle V, Courtois V, Giraud G, Dastugue B, Boespflug-Tanguy O. 2000. Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Clinical European Network on Brain Dysmyelinating Disease. Eur J Hum Genet 8:837-845.
11. Charrin S, le Naour F, Silvie O, Milhiet PE, Boucheix C, Rubinstein E. 2009. Lateral organization of membrane proteins: Tetraspanins spin their web. Biochem J 420:133-154.
12. Charrin S, Manie S, Thiele C, Billard M, Gerlier D, Boucheix C, Rubinstein E. 2003. A physical and functional link between cholesterol and tetraspanins. Eur J Immunol 33:2479-2489.
13. Chow E, Mottahedeh J, Prins M, Ridder W, Nusinowitz S, Bronstein JM. 2005. Disrupted compaction of CNS myelin in an OSP/Claudin-11 and PLP/DM20 double knockout mouse. Mol Cell Neurosci 29:405-413.
14. Claas C, Stipp CS, Hemler ME. 2001. Evaluation of prototype transmembrane 4 superfamily protein complexes and their relation to lipid rafts. J Biol Chem 276:7974-7984.
15. de Monasterio-Schrader P, Jahn O, Tenzer S, Wichert SP, Patzig J, Werner HB. 2012. Systematic approaches to central nervous system myelin. Cell Mol Life Sci 69:2879-2894.
16. Dhaunchak AS, Nave KA. 2007. A common mechanism of PLP/DM20 misfolding causes cysteine-mediated endoplasmic reticulum retention in oligodendrocytes and Pelizaeus-Merzbacher disease. Proc Natl Acad Sci U S A 104:17813-17818.
17. Donmez G, Outeiro TF. 2013. SIRT1 and SIRT2: Emerging targets in neurodegeneration. EMBO Mol Med 5:344-352.
18. Dugas JC, Tai YC, Speed TP, Ngai J, Barres BA. 2006. Functional genomic analysis of oligodendrocyte differentiation. J Neurosci 26:10967-10983.
19. Duncan ID. 2005. The PLP mutants from mouse to man. J Neurol Sci 228:204-205.
20. Edgar JM, McLaughlin M, Werner HB, McCulloch MC, Barrie JA, Brown A, Faichney AB, Snaidero N, Nave KA, Griffiths IR. 2009. Early ultrastructural defects of axons and axon-glia junctions in mice lacking expression of Cnp1. Glia 57:1815-1824.
21. Edgar JM, McLaughlin M, Yool D, Zhang SC, Fowler JH, Montague P, Barrie JA, McCulloch MC, Duncan ID, Garbern J, et al. 2004. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J Cell Biol 166:121-131.
22. Edgar JM, Nave KA. 2009. The role of CNS glia in preserving axon function. Curr Opin Neurobiol 19:498-504.
23. Emery B, Agalliu D, Cahoy JD, Watkins TA, Dugas JC, Mulinyawe SB, Ibrahim A, Ligon KL, Rowitch DH, Barres BA. 2009. Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination. Cell 138:172-185.
24. Fitzner D, Schnaars M, van Rossum D, Krishnamoorthy G, Dibaj P, Bakhti M, Regen T, Hanisch UK, Simons M. 2011. Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J Cell Sci 124(Pt 3):447-458.
25. Gallyas F. 1979. Silver staining of myelin by means of physical development. Neurol Res 1:203-209.
26. Geisert EE Jr., Williams RW, Geisert GR, Fan L, Asbury AM, Maecker HT, Deng J, Levy S. 2002. Increased brain size and glial cell number in CD81-null mice. J Comp Neurol 453:22-32.
27. Gitik M, Liraz-Zaltsman S, Oldenborg PA, Reichert F, Rotshenker S. 2011. Myelin down-regulates myelin phagocytosis by microglia and macrophages through interactions between CD47 on myelin and SIRPalpha (signal regulatory protein-alpha) on phagocytes. J Neuroinflammation 8:24.
28. Gow A, Southwood CM, Li JS, Pariali M, Riordan GP, Brodie SE, Danias J, Bronstein JM, Kachar B, Lazzarini RA. 1999. CNS myelin and sertoli cell tight junction strands are absent in Osp/claudin-11 null mice. Cell 99:649-659.
29. Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, Schwab MH, Schneider A, Zimmermann F, McCulloch M, Nadon N, et al. 1998. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280:1610-1613.
30. Gruenenfelder FI, Thomson G, Penderis J, Edgar JM. 2011. Axon-glial interaction in the CNS: What we have learned from mouse models of Pelizaeus-Merzbacher disease. J Anat 219:33-43.
31. Hagemeyer N, Goebbels S, Papiol S, Kastner A, Hofer S, Begemann M, Gerwig UC, Boretius S, Wieser GL, Ronnenberg A, et al. 2012. A myelin gene causative of a catatonia-depression syndrome upon aging. EMBO Mol Med 4:528-539.
32. Han MH, Lundgren DH, Jaiswal S, Chao M, Graham KL, Garris CS, Axtell RC, Ho PP, Lock CB, Woodard JI, Brownell SE, Zoudilova M, Hunt JF, Baranzini SE, Butcher EC, Raine CS, Sobel RA, Han DK, Weissman I, Steinman L. 2012. Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice. J Exp Med 209:1325-1334.
33. Hanisch UK. 2013. Proteins in microglial activation - inputs and outputs by subsets. Curr Protein Pept Sci 14:3-15.
34. Harting K, Knoll B. 2010. SIRT2-mediated protein deacetylation: An emerging key regulator in brain physiology and pathology. Eur J Cell Biol 89:262-269.
35. Hemler ME. 2005. Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol 6:801-811.
36. Hemler ME. 2008. Targeting of tetraspanin proteins--potential benefits and strategies. Nat Rev Drug Discov 7:747-758.
37. Ho PP, Kanter JL, Johnson AM, Srinagesh HK, Chang EJ, Purdy TM, van Haren K, Wikoff WR, Kind T, Khademi M, et al. 2012. Identification of naturally occurring fatty acids of the myelin sheath that resolve neuroinflammation. Sci Transl Med 4137ra73.
38. Hobson GM, Garbern JY. 2012. Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher-like disease 1, and related hypomyelinating disorders. Semin Neurol 32:62-67.
39. Huttemann M, Zhang Z, Mullins C, Bessert D, Lee I, Nave KA, Appikatla S, Skoff RP. 2009. Different proteolipid protein mutants exhibit unique metabolic defects. ASN Neuro 1.
40. Ikenaka K, Kagawa T. 1995. Transgenic systems in studying myelin gene expression. Dev Neurosci 17:127-136.
41. Ishibashi T, Ding L, Ikenaka K, Inoue Y, Miyado K, Mekada E, Baba H. 2004. Tetraspanin protein CD9 is a novel paranodal component regulating paranodal junctional formation. J Neurosci 24:96-102.
42. Jahn O, Tenzer S, Bartsch N, Patzig J, Werner HB. 2013. Myelin proteome analysis: Methods and implications for the myelin cytoskeleton. Neuromethods 79:335-353.
43. Jahn O, Tenzer S, Werner HB. 2009. Myelin proteomics: Molecular anatomy of an insulating sheath. Mol Neurobiol 40:55-72.
44. Jaiswal S, Jamieson CH, Pang WW, Park CY, Chao MP, Majeti R, Traver D, van Rooijen N, Weissman IL. 2009. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 138:271-285.
45. Jones EL, Demaria MC, Wright MD. 2011. Tetraspanins in cellular immunity. Biochem Soc Trans 39:506-511.
46. Jung M, Sommer I, Schachner M, Nave KA. 1996. Monoclonal antibody O10 defines a conformationally sensitive cell-surface epitope of proteolipid protein (PLP): Evidence that PLP misfolding underlies dysmyelination in mutant mice. J Neurosci 16:7920-7929.
47. Junker A, Krumbholz M, Eisele S, Mohan H, Augstein F, Bittner R, Lassmann H, Wekerle H, Hohlfeld R, Meinl E. 2009. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 132(Pt 12):3342-3352.
48. Kagawa T, Mekada E, Shishido Y, Ikenaka K. 1997. Immune system-related CD9 is expressed in mouse central nervous system myelin at a very late stage of myelination. J Neurosci Res 50:312-320.
49. Kassmann CM, Lappe-Siefke C, Baes M, Brugger B, Mildner A, Werner HB, Natt O, Michaelis T, Prinz M, Frahm J, et al. 2007. Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat Genet 39:969-976.
50. Klugmann M, Schwab MH, Puhlhofer A, Schneider A, Zimmermann F, Griffiths IR, Nave KA. 1997. Assembly of CNS myelin in the absence of proteolipid protein. Neuron 18:59-70.
51. Krämer-Albers E-M, Bretz N, Tenzer S, Winterstein C, Möbius W, Berger H, Nave K-A, Schild H, Trotter J. 2007. Oligodendrocytes secrete exosomes containing major myelin and stress-protective proteins: Trophic support for axons? Proteomics Clin Appl 1:1446-1461.
52. Langer M, Sah R, Veser A, Gutlich M, Langosch D. 2013. Structural properties of model phosphatidylcholine flippases. Chem Biol 20:63-72.
53. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, Griffiths IR, Nave KA. 2003. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33:366-374.
54. Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A, Boe AF, Boguski MS, Brockway KS, Byrnes EJ, et al. 2007. Genome-wide atlas of gene expression in the adult mouse brain. Nature 445:168-176.
55. Levy S, Shoham T. 2005. The tetraspanin web modulates immune-signalling complexes. Nat Rev Immunol 5:136-148.
56. Levy S, Todd SC, Maecker HT. 1998. CD81 (TAPA-1): A molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol 16:89-109.
57. Mathivanan S, Simpson RJ. 2009. ExoCarta: A compendium of exosomal proteins and RNA. Proteomics 9:4997-5000.
58. Mela A, Goldman JE. 2009. The tetraspanin KAI1/CD82 is expressed by late-lineage oligodendrocyte precursors and may function to restrict precursor migration and promote oligodendrocyte differentiation and myelination. J Neurosci 29:11172-11181.
59. Möbius W, Cooper B, Kaufmann WA, Imig C, Ruhwedel T, Snaidero N, Saab AS, Varoqueaux F. 2010. Electron microscopy of the mouse central nervous system. Methods Cell Biol 96:475-512.
60. Möbius W, Patzig J, Nave KA, Werner HB. 2008. Phylogeny of proteolipid proteins: Divergence, constraints, and the evolution of novel functions in myelination and neuroprotection. Neuron Glia Biol 4:111-127.
61. Morell P, Jurevics H. 1996. Origin of cholesterol in myelin. Neurochem Res 21:463-470.
62. Nakamura Y, Iwamoto R, Mekada E. 1996. Expression and distribution of CD9 in myelin of the central and peripheral nervous systems. Am J Pathol 149:575-583.
63. Nave KA. 2010. Myelination and support of axonal integrity by glia. Nature 468:244-252.
64. Nielsen JA, Maric D, Lau P, Barker JL, Hudson LD. 2006. Identification of a novel oligodendrocyte cell adhesion protein using gene expression profiling. J Neurosci 26:9881-9891.
65. Norton WT, Poduslo SE. 1973. Myelination in rat brain: Changes in myelin composition during brain maturation. J Neurochem 21:759-773.
66. Ohmi Y, Tajima O, Ohkawa Y, Yamauchi Y, Sugiura Y, Furukawa K. 2011. Gangliosides are essential in the protection of inflammation and neurodegeneration via maintenance of lipid rafts: Elucidation by a series of ganglioside-deficient mutant mice. J Neurochem 116:926-935.
67. Olah M, Amor S, Brouwer N, Vinet J, Eggen B, Biber K, Boddeke HW. 2012. Identification of a microglia phenotype supportive of remyelination. Glia 60:306-321.
68. Ousman SS, Tomooka BH, van Noort JM, Wawrousek EF, O'Connor KC, Hafler DA, Sobel RA, Robinson WH, Steinman L. 2007. Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination. Nature 448:474-479.
69. Palin K, Cunningham C, Forse P, Perry VH, Platt N. 2008. Systemic inflammation switches the inflammatory cytokine profile in CNS Wallerian degeneration. Neurobiol Dis 30:19-29.
70. Parakalan R, Jiang B, Nimmi B, Janani M, Jayapal M, Lu J, Tay SS, Ling EA, Dheen ST. 2012. Transcriptome analysis of amoeboid and ramified microglia isolated from the corpus callosum of rat brain. BMC Neurosci 13:64.
71. Park SY, Yoon SJ, Freire-de-Lima L, Kim JH, Hakomori SI. 2009. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells. Carbohydr Res 344:1479-1486.
72. Patzig J, Jahn O, Tenzer S, Wichert SP, de Monasterio-Schrader P, Rosfa S, Kuharev J, Yan K, Bormuth I, Bremer J, et al. 2011. Quantitative and integrative proteome analysis of peripheral nerve myelin identifies novel myelin proteins and candidate neuropathy loci. J Neurosci 31:16369-16386.
73. Rana S, Zoller M. 2011. Exosome target cell selection and the importance of exosomal tetraspanins: A hypothesis. Biochem Soc Trans 39:559-562.
74. Ransohoff RM. 2007. Inflammatory disease: Assault on the guardian. Nature 448:421-422.
75. Saugier-Veber P, Munnich A, Bonneau D, Rozet JM, Le Merrer M, Gil R, Boespflug-Tanguy O. 1994. X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat Genet 6:257-262.
76. Schaeren-Wiemers N, Bonnet A, Erb M, Erne B, Bartsch U, Kern F, Mantei N, Sherman D, Suter U. 2004. The raft-associated protein MAL is required for maintenance of proper axon--glia interactions in the central nervous system. J Cell Biol 166:731-742.
77. Schneider A, Montague P, Griffiths I, Fanarraga M, Kennedy P, Brophy P, Nave KA. 1992. Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene. Nature 358:758-761.
78. Schweitzer J, Becker T, Schachner M, Nave KA, Werner H. 2006. Evolution of myelin proteolipid proteins: Gene duplication in teleosts and expression pattern divergence. Mol Cell Neurosci 31:161-177.
79. Sierra A, Abiega O, Shahraz A, Neumann H. 2013. Janus-faced microglia: Beneficial and detrimental consequences of microglial phagocytosis. Front Cell Neurosci 7:6.
80. Simons M, Kramer EM, Thiele C, Stoffel W, Trotter J. 2000. Assembly of myelin by association of proteolipid protein with cholesterol- and galactosylceramide-rich membrane domains. J Cell Biol 151:143-154.
81. Simons M, Raposo G. 2009. Exosomes--vesicular carriers for intercellular communication. Curr Opin Cell Biol 21:575-581.
82. Skripuletz T, Hackstette D, Bauer K, Gudi V, Pul R, Voss E, Berger K, Kipp M, Baumgartner W, Stangel M. 2013. Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination. Brain 136(Pt 1):147-167.
83. Smith KJ, Kapoor R, Hall SM, Davies M. 2001. Electrically active axons degenerate when exposed to nitric oxide. Ann Neurol 49:470-476.
84. Smith KJ, Lassmann H. 2002. The role of nitric oxide in multiple sclerosis. Lancet Neurol 1:232-241.
85. Stipp CS, Kolesnikova TV, Hemler ME. 2003. Functional domains in tetraspanin proteins. Trends Biochem Sci 28:106-112.
86. Sullivan CD, Geisert EE Jr. 1998. Expression of rat target of the antiproliferative antibody (TAPA) in the developing brain. J Comp Neurol 396:366-380.
87. Terada N, Baracskay K, Kinter M, Melrose S, Brophy PJ, Boucheix C, Bjartmar C, Kidd G, Trapp BD. 2002. The tetraspanin protein, CD9, is expressed by progenitor cells committed to oligodendrogenesis and is linked to beta1 integrin, CD81, and Tspan-2. Glia 40:350-359.
88. Todeschini AR, Dos Santos JN, Handa K, Hakomori SI. 2007. Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse. J Biol Chem 282:8123-8133.
89. Toledo MS, Suzuki E, Handa K, Hakomori S. 2005. Effect of ganglioside and tetraspanins in microdomains on interaction of integrins with fibroblast growth factor receptor. J Biol Chem 280:16227-16234.
90. Tsai YC, Weissman AM. 2011. Dissecting the diverse functions of the metastasis suppressor CD82/KAI1. FEBS Lett 585:3166-3173.
91. van Spriel AB. 2011. Tetraspanins in the humoral immune response. Biochem Soc Trans 39:512-517.
92. Werner H, Jung M, Klugmann M, Sereda M, Griffiths IR, Nave KA. 1998. Mouse models of myelin diseases. Brain Pathol 8:771-793.
93. Werner HB, Jahn O. 2010. Myelin matters: Proteomic insights into white matter disorders. Expert Rev Proteomics 7:159-164.
94. Werner HB, Kramer-Albers EM, Strenzke N, Saher G, Tenzer S, Ohno-Iwashita Y, De Monasterio-Schrader P, Mobius W, Moser T, Griffiths IR, Nave KA. 2013. A critical role for the cholesterol-associated proteolipids PLP and M6B in myelination of the central nervous system. Glia 61:567-586.
95. Werner HB, Kuhlmann K, Shen S, Uecker M, Schardt A, Dimova K, Orfaniotou F, Dhaunchak A, Brinkmann BG, Möbius W, Guarente L, Casaccia-Bonnefil P, Jahn O, Nave KA. 2007. Proteolipid protein is required for transport of sirtuin 2 into CNS myelin. J Neurosci 27:7717-7730.
96. Wieser GL, Gerwig UC, Adamcio B, Barrette B, Nave KA, Ehrenreich H, Goebbels S. 2013. Neuroinflammation in white matter tracts of Cnp1 mutant mice amplified by a minor brain injury. Glia 61:869-880.
97. Yin X, Baek RC, Kirschner DA, Peterson A, Fujii Y, Nave KA, Macklin WB, Trapp BD. 2006. Evolution of a neuroprotective function of central nervous system myelin. J Cell Biol 172:469-478.
98. Yool DA, Klugmann M, McLaughlin M, Vouyiouklis DA, Dimou L, Barrie JA, McCulloch MC, Nave KA, Griffiths IR. 2001. Myelin proteolipid proteins promote the interaction of oligodendrocytes and axons. J Neurosci Res 63:151-164.
99. Yu Y, Chen Y, Kim B, Wang H, Zhao C, He X, Liu L, Liu W, Wu LM, Mao M, et al. 2013. Olig2 targets chromatin remodelers to enhancers to initiate oligodendrocyte differentiation. Cell 152:248-261.
100. Zamanian JL, Xu L, Foo LC, Nouri N, Zhou L, Giffard RG, Barres BA. 2012. Genomic analysis of reactive astrogliosis. J Neurosci 32:6391-6410.
101. Zeis T, Schaeren-Wiemers N. 2008. Lame ducks or fierce creatures? The role of oligodendrocytes in multiple sclerosis. J Mol Neurosci 35:91-100.